|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1993-5-4
|
|
pubmed:abstractText |
G-CSF administration leads to significant elevation in the levels of circulating progenitor cells. Infusion of these cells after high-dose chemotherapy is associated with accelerated platelet engraftment that has a considerable impact in shortening thrombocytopenia and reducing need for platelet transfusions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0301-4800
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
Spec No
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
368-71
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1284309-Adult,
pubmed-meshheading:1284309-Antineoplastic Agents,
pubmed-meshheading:1284309-Blood Component Transfusion,
pubmed-meshheading:1284309-Bone Marrow Transplantation,
pubmed-meshheading:1284309-Cells, Cultured,
pubmed-meshheading:1284309-Colony-Forming Units Assay,
pubmed-meshheading:1284309-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:1284309-Hematopoietic Stem Cells,
pubmed-meshheading:1284309-Humans,
pubmed-meshheading:1284309-Middle Aged,
pubmed-meshheading:1284309-Risk Factors,
pubmed-meshheading:1284309-Thrombocytopenia,
pubmed-meshheading:1284309-Transplantation, Autologous
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
G-CSF mobilised progenitor cells in autologous transplantation: in vitro and in vivo aspects.
|
|
pubmed:affiliation |
The Royal Melbourne Hospital, Victoria, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
